Blog

Dengue has become one of India's biggest public health concerns. Every year, especially during the monsoon season, thousands of people are diagnosed with dengue, leading to hospitalizations and, in severe cases, life-threatening complications. While mosquito control, preventive measures, and early diagnosis have always been the primary ways to fight dengue, India has now taken a major step forward.
The Qdenga vaccine has received approval from the Drug Controller General of India (DCGI), making it India's first dengue vaccine approved for use. This marks a significant milestone in protecting people against one of the country's most common mosquito-borne diseases.
But what exactly is Qdenga? Who can take it? How many doses are needed? What is the expected Qdenga vaccine price in India? Is it safe?
Qdenga is a dengue vaccine developed to protect people against all four dengue virus serotypes (DENV-1, DENV-2, DENV-3, and DENV-4).
Unlike some earlier dengue vaccines that had limitations based on whether a person had previously been infected with dengue, Qdenga has been designed for broader use and has shown protection against symptomatic dengue as well as severe dengue in clinical studies.
The vaccine has already been approved in several countries around the world. Now, with DCGI approval, the Qdenga vaccine in India becomes the country's first approved dengue vaccine, opening a new chapter in dengue prevention.
India reports a large number of dengue infections every year. The disease spreads rapidly during and after the monsoon because mosquitoes breed in stagnant water.
Although many patients recover with proper care, dengue can sometimes progress to severe dengue, causing:
Until now, prevention mainly depended on:
The approval of India's first dengue vaccine adds another important layer of protection. While vaccination does not replace mosquito control, it can help reduce the risk of symptomatic disease and severe illness.
Qdenga helps the body's immune system recognize the dengue virus before a real infection occurs.
After vaccination:
Since dengue has four different virus types, protection against multiple serotypes is extremely important. Qdenga has been developed with this in mind.
One of the most common questions people have is about eligibility.
Current approval in India is based on DCGI clearance. The detailed rollout strategy, availability, and recommendations may evolve as public health authorities issue implementation guidelines.
In general, international approvals have included individuals in the age group of 4 years and above, depending on country-specific recommendations.
People should always consult their healthcare provider before vaccination, especially if they:
As more guidance becomes available in India, doctors will be able to advise who should receive the vaccine and under what circumstances.
Vaccination may need to be postponed or avoided in certain situations.
These include:
Always discuss your medical history before getting vaccinated.
One of the most searched questions is about Qdenga vaccine dosage.
The approved schedule consists of:
Receiving both doses is important because they work together to provide better protection.
Missing the second dose may reduce the overall effectiveness of the vaccination.
If you are planning to get vaccinated, try to complete the schedule as advised by your healthcare provider.
Vaccines often require multiple doses because the immune system responds better with repeated exposure.
The first dose helps the body recognize the virus.
The second dose strengthens immune memory, improving long-term protection.
This is why completing the full Qdenga vaccine dosage schedule is important instead of stopping after one injection.
Many people are already searching for the Qdenga vaccine price India.
Since the vaccine has recently received approval, the official market price may vary depending on:
At the time of writing, the final retail pricing and large-scale commercial availability across India are still being announced.
Patients are advised to check with authorized hospitals and vaccination centres for the latest pricing once the rollout begins.
Whether it's a new vaccine, a dengue test, or a preventive health check-up, staying informed helps you make better healthcare decisions.
With Curelo, you can compare diagnostic labs, book blood tests online, and choose home sample collection from trusted partner laboratories. If you develop dengue symptoms such as high fever, body pain, or rash, getting tested early can help ensure timely medical care.
Safety is naturally one of the biggest concerns whenever a new vaccine is introduced.
Qdenga has undergone:
Like all vaccines, mild side effects can occur.
These usually include:
These symptoms generally disappear within a few days.
Serious reactions are considered uncommon, but immediate medical attention should be sought if severe allergic symptoms develop after vaccination.
Yes.
No vaccine offers 100% protection.
However, vaccination can significantly reduce the risk of:
This means vaccinated individuals may still get infected but are expected to have better protection against serious disease.
Absolutely not.
Vaccination should be seen as an additional protective measure.
You should still:
Combining vaccination with mosquito control offers the best protection.
Even after vaccination, early diagnosis remains extremely important.
If you experience symptoms such as:
Consult a doctor immediately.
Doctors may recommend tests such as:
Early testing helps doctors monitor platelet count and detect complications before they become severe.
Many people think dengue only causes fever.
In reality, severe dengue can lead to:
This is why medical supervision is extremely important, especially during days 3–7 of illness.
The approval of India's first dengue vaccine could have several long-term benefits.
These include:
However, vaccination should work alongside surveillance, mosquito control, public awareness, and timely medical care.
If dengue cases are rising in your area, don't wait for symptoms to become severe.
Compare nearby diagnostic labs, book dengue tests online, and schedule home sample collection through Curelo for added convenience. Early diagnosis and prompt medical advice remain essential, even as vaccines become available.
Here's a quick summary:
The approval of the Qdenga vaccine in India is an important step in India's fight against dengue, but prevention continues to require a combination of vaccination, mosquito control, public awareness, and timely healthcare.
The approval of the Qdenga vaccine in India marks a major milestone in India's public health journey. As India's first dengue vaccine, it offers a promising new way to strengthen dengue prevention alongside mosquito control and early medical care.
While the Qdenga vaccine dosage follows a simple two-dose schedule, and information about the Qdenga vaccine price in India becomes clearer with wider rollout, one thing remains unchanged: awareness, prevention, and early diagnosis are still the most effective tools in reducing dengue-related complications.
Stay informed, protect yourself from mosquito bites, complete recommended vaccinations when eligible, and never ignore dengue symptoms. With timely testing, proper medical care, and informed decisions, we can all contribute to reducing the impact of dengue in India.
Qdenga is India's first approved dengue vaccine after receiving DCGI approval. It is designed to protect against all four dengue virus serotypes and aims to reduce the risk of symptomatic and severe dengue. It complements existing preventive measures such as mosquito control and early diagnosis.
The recommended Qdenga vaccine dosage consists of two injections given three months apart. Completing both doses is important because the second dose strengthens the immune response and provides better overall protection.
The exact Qdenga vaccine price in India may differ depending on the healthcare provider, city, and availability. Since the vaccine has recently been approved, pricing is expected to become clearer as commercial rollout begins. It is best to check with authorized hospitals or vaccination centres for the latest information.
Current international approvals generally include people aged 4 years and above, although recommendations in India may continue to evolve as health authorities release implementation guidelines. A healthcare professional can determine whether the vaccine is appropriate based on age, health status, and medical history.
Yes. No vaccine offers complete protection. However, vaccination is expected to reduce the chances of severe dengue, hospitalization, and serious complications. It is still important to prevent mosquito bites and seek medical care if symptoms appear.
No. Even after vaccination, you should continue using mosquito repellents, wear protective clothing, remove stagnant water around your home, and follow other mosquito-control measures. Vaccination is an added layer of protection, not a replacement.
If you experience symptoms such as high fever, severe body pain, headache, rash, vomiting, or bleeding, consult a doctor immediately. Early diagnosis with tests like Dengue NS1, IgM, IgG, and CBC can help doctors monitor your condition and begin appropriate treatment without delay.
If your doctor recommends testing, you can compare diagnostic laboratories, check prices, and book dengue blood tests through trusted healthcare platforms like Curelo. Choosing a reliable lab and getting tested early can support faster diagnosis and timely treatment, especially during the peak dengue season.
Share Your Details, We Will Call You Right Back!